Artemis Therapeutics, Inc. (ATMS)

Overview

Artemis Therapeutics Inc. is a New York-based company that currently operates without significant business activities. Once at the forefront of innovative medical research, the company was dedicated to the development of pharmaceutical agents aimed at preventing and treating severe and life-threatening infectious diseases. As a subsidiary of Tonak Ltd., Artemis Therapeutics Inc. possesses a lineage of corporate backing that supports its foundational goals, though it currently remains in a phase of operational inactivity.

Products and Services

• Pharmaceutical Development

  Artemis Therapeutics Inc. previously focused on the research and development of pharmaceutical agents. This included the exploratory phases of creating innovative therapies to combat serious infectious diseases that pose threats to public health.

• Clinical Research

  The company's groundwork involved the design and implementation of clinical trials aimed at assessing the efficacy and safety of its potential treatments. This rigorous process is critical in the pharmaceutical industry, especially for agents intended for severe diseases.

• Partnerships and Collaborations

  The potential to engage in partnerships with other pharmaceutical or biotech companies, research institutions, or healthcare organizations was a key aspect of Artemis Therapeutics Inc.'s strategy, enhancing the scope of research and extending resources for product development.

• Advisory Services

  In past operational phases, Artemis Therapeutics Inc. may have offered advisory services related to regulatory compliance and drug development strategies, leveraging its expertise in navigating the complex landscape of pharmaceutical regulations.